Company intelligence / Profile preview
CardioCell LLC
San Diego, California, United Statesstemcardiocell.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
CardioCell has completed a Phase IIa clinical trial for chronic heart failure using itMSCs delivered intravenously, showing safety and improvements in patient well-being. The trial demonstrated statistically significant improvements in the 6-minute walk test and KCCQ Clinical Summary score, as well as reduction in inflammation markers. The company planned to proceed with Phase IIb trials based on these promising results[4][7].
- Therapeutic areas
- Cardiovascular
- Modalities
- Ischemia-tolerant mesenchymal stem cells (itMSCs)allogeneic stem cells
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
MedStar Heart & Vascular InstituteMedStar Health
Beyond the preview
Go deeper on CardioCell LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CardioCell LLC.